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Abstract 
 
Bacground/Aim. The efficient dental anesthesia, which is 
related to the clinically adequate depth, duration and the 
width of anesthetic field, is an important prerequisite for 
successful dental treatment. The aim of this study was to in-
vestigate and compare the pulpal anesthesia and cardiovas-
cular parameters after the anterior middle superior alveolar 
(AMSA) nerve block with 4% articaine with epinephrine 
administered by conventional cartridge-syringe and com-
puter-controlled local anesthetic delivery system (CCLADS). 
Methods. This controlled double-blind cross-over random-
ized clinical study included 38 healthy volunteers. Efficacy 
of pulpal anesthesia after the AMSA nerve block was evalu-
ated by measuring a success rate, onset and duration of pul-
pal anesthesia, using an electrical pulp tester. The parame-
ters of cardiovascular function (systolic and diastolic blood 
pressure, heart rate) were monitored noninvasively. Re-
sults. Successful pulpal anesthesia of all tested teeth was 
obtained in 57.9% participants with CCLADS and in 44.7% 
participants with conventional syringe. The onset time was 
not significantly different between two investigated groups. 
The pulpal anesthesia duration was not significantly differ-
ent neither within nor between investigated groups. The 
systolic and diastolic blood pressures were significantly de-
creased in both investigated groups, in comparison with the 
baseline values. Heart rate significantly decreased within 
CCLADS from 10th to 30th minute when compared to 
baseline. Conclusion. The efficacy of pulpal anesthesia and 
safety of cardiovascular profile of 0.6 mL of articaine with 
epinephrine (1:100.000) delivered with CCLADS were im-
proved in comparison to the conventional syringe delivery. 
Significant changes of cardiovascular function were not ob-
served. 
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Apstrakt 
 
Uvod/Cilj. Efikasna zubna anestezija u pogledu klinički 
adekvatne dubine, trajanja i širine anestetičkog polja je 
važan preduslov za uspešno zubno lečenje. Cilj rada bio je 
ispitivanje i upoređivanje parametra anestezije zubne pulpe i 
kardiovaskularnih parametra posle gornje prednje i srednje 
alveolarne (AMSA) sprovodne anestezije postignute 4% ar-
tikainom sa epinefrinom, primenom standardne karpul-
brizgalice i kompjuterski kontrolisanog sistema za primenu 
anestetičkog rastvora (CCLADS). Metode. U ovom ran-
domizovanom, prospektivnom, kontrolisanom, dvostruko 
slepom ukrštenom kliničkom istraživanju učestvovalo je 38 
ispitanika. Kvalitet anestezije zubne pulpe posle AMSA 
anestezije praćen je na osnovu uspešnosti, latentnog perioda 
i trajanja anestezije zubne pulpe, primenom električnog 
pulp-testera. Parametri kardiovaskularne funkcije (sistolni i 
dijastolni krvni pritisak, srčana frekvencija) praćeni su nein-
vazivno, primenom aparata za monitoring. Rezultati. Us-
pešna anestezija zubne pulpe svih ispitivanih zuba bila je 
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prisutna kod 57,9% ispitanika posle kod CCLADS i kod 
44,7% ispitanika posle primene standardne karpul-brizga-
lice. Latentni period i trajanje anestezije zubne pulpe nisu se 
značajno razlikovali između ispitivanih grupa. Sistolni i di-
jastolni pritisak bili su značajno sniženi u praćenim vremen-
skim intervalima u odnosu na početne vrednosti. Srčana 
frekvencija je bila značajno snižena kod CCLADS grupe od 10 
do 30 minuta u odnosu na početne vrednosti. Zaključak. 
Kontrolisanom kompjuterizovanom primenom (CCLADS) 
0,6 mL 4% artikaina sa epinefrinom (1:100,000) za AMSA 
sprovodnu anesteziju, postignut je bolji kvalitet anestezije 
zubne pulpe u odnosu na primenu artikaina sa epinefrinom 
standardnom karpul brizgalicom. Nisu uočene bitne pro-
mene funkcija kardiovaskularnog sistema. 
 
Ključne reči: 
artikain; anestezija, stomatološka; anestezija, lokalna; 
lečenje, kompjuterom vođeno; blokada živca; injekcije. 
 
Introduction 
The efficient dental anesthesia, which is related to the 
clinically adequate depth, duration and the width of anes-
thetic field, is an important prerequisite for successful dental 
treatment. Most commonly, the pulp of the maxillary teeth, 
surrounding bone and soft tissue are anesthetized by buccal 
supraperiosteal infiltration of local anesthetic in the projec-
tion of the tooth apex 1. Recently, the anterior middle supe-
rior alveolar (AMSA) nerve block has been introduced as a 
technique which provides pulpal anesthesia of multiple max-
illary teeth with single site injection, without collateral anes-
thesia of lip, face and muscles of facial expression 2. The lo-
cal anesthetic solution for the AMSA nerve block is depos-
ited palatal, at the point which bisects the maxillary premo-
lars, and midway between the mid-palatal raphe and premo-
lar free gingival margin crest. The target area is the anatomi-
cal region where the anterior superior alveolar (ASA) and the 
medial superior alveolar (MSA) nerves’ branches converge 
and form the dental neural plexus. Therefore, an anesthetic 
effect of a single AMSA block injection extends to the pulpal 
tissue of maxillary teeth from the central incisor through the 
second premolar, innervated by the ASA and MSA nerves, 
with additional anesthesia of soft palatal tissue in the same 
region.  
Generally, the palatal injections with a conventional sy-
ringe have the potential to be unpleasant and painful. The 
new approach in the dental anesthesia techniques develops 
systems of controlled anesthetic delivery is aimed to reduce 
not only a patient’s discomfort during palatal soft tissue an-
esthesia, but also to increase quality of bone and dental pulp 
anesthesia. Some of the published studies using this com-
puter-controlled local anesthetic delivery system (CCLADS) 
for the AMSA nerve block, showed that continuous and con-
trolled dosage of 2% lidocaine with epinephrine may achieve 
profound pulpal anesthesia from central incisor through sec-
ond premolar, what was not seen after conventional deliv-
ery 2–4. Although obtained clinical results were more favor-
able with the CCLADS than with conventional delivery, the 
modest to low success rate, slow onset and rapid anesthesia 
duration declining observed after 2% lidocaine with epineph-
rine may decrease the clinical utilization of AMSA nerve 
block due to the anatomical properties of palatal injection 
site, as well as pharmacological properties of lidocaine with 
epinephrine solution 5, 6. 
Since the AMSA nerve block is obtained following dif-
fusion of local anesthetic solution through the palatal bone 
before reaching the dental nerve plexus, the characteristics of 
local anesthetic could influence the parameters of local anes-
thesia. Articaine is an amide local anesthetic with the unique 
properties due to the characteristics of thiophene ring in its 
structure, which ensures that a diffusing property of articaine 
through soft and hard tissues is more pronounced than of 
other amide local anesthetics 7. There is evidence that palatal 
soft tissue anesthesia occasionally may be obtained by arti-
caine diffusion after maxillary infiltration without an addi-
tional palatal injection 8–10. 
To our knowledge, there are no data concerning the ef-
ficacy and safety of AMSA nerve block obtained with 4% ar-
ticaine with epinephrine. Therefore, the aim of this study was 
to investigate and compare the parameters of pulpal anesthe-
sia and cardiovascular functions after the AMSA nerve block 
with 4% articaine with epinephrine administered by a con-
ventional syringe and the CCLADS.  
Methods 
This prospective, double-blind cross-over randomized 
study included the healthy volunteers [American Socity of 
Anesthesiologists (ASA) I] who were admitted for the regu-
lar dental examination at the Clinic of Oral Surgery, School 
of Dental Medicine, University of Belgrade, Serbia. After 
approval of the Ethics committee of the School of Dental 
Medicine (36/5-2015), the study was performed in accor-
dance with ethical standards laid down in 1964 Declaration 
of Helsinki and its later amendments. The United States Na-
tional Institutes of Health Clinical Trial registration was per-
formed (ClinicalTrials.gov: NCT02440347). All participants 
signed the informed consent after they were informed in de-
tails, verbally and in written form, about the study proce-
dures and possible side effects.  
Participants’ eligibility  
Inclusion criteria were as follows: full maxillary dental 
arch with all maxillary teeth free of caries and restorations, 
without history of trauma, sensitivity or orthodontic treat-
ment, with a visible pulpal chamber on intraoral radiogram, 
responsive to electrical stimulation by the pulp tester and 
clinically and radiographically healthy periodontium. The al-
lergy to local anesthetics, presence of orofacial pain, and/or use 
of any medicine within the previous 48 hours, pregnancy, lacta-
tion, drug and/or alcohol abuse, tobacco smoking and inhibi-
tion to give informed consent were exclusion criteria. 
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Study procedure 
The patients served as their own control in cross-over 
design. The AMSA injection on one side of the maxillary 
arch was administered using CCLADS (Anaeject®, Septo-
dont, France) while conventional cartridge-syringe was used 
for the opposite side. The AMSA injection site was located 
at a point that bisects the maxillary first and second premo-
lars, and midway between the crest of the free gingival mar-
gin and mid-palatine suture. The needle was orientated at a 
45 degree angle with the bevel facing palatal tissue. All den-
tal anesthesia glass cartridges were marked at the level of 0.6 
mL of anesthetic solution. The 0.6 mL of 4% articaine with 
epinephrine 1:100 000 was administered in two minutes pe-
riod, both with CCLADS, or conventional cartridge-syringe. 
CCLADS enabled a slow and constant administration of an-
esthetic, approximately 0.005 mL per second. The sound 
mode during the administration of local anesthetic with 
CCLADS was switched off, in order to disable the patient to 
distinguish the method of administration. The patients were 
instructed to rest prior to the injection in supine position for 
15 minutes in an isolated dental office. In addition, the pa-
tients were blindfolded with a commonly used sleeping mask 
so they would not distinguish which anesthetic delivery sys-
tem was used. The same operator administered anesthesia of 
both sides and was excluded from measuring data and statis-
tical analysis. The order of anesthesia techniques was blind-
ed and randomly selected from a sealed envelope for each 
patient, with a washout period of 2 weeks between the ap-
pointments. 
Parameters of pulpal anesthesia 
The pulpal anesthesia parameters were tested in the fol-
lowing teeth: upper central and lateral incisor, canine, first 
premolar and second premolar with contralateral canine as a 
control tooth.  
The anesthetic success, onset and duration were regis-
tered with the electrical pulp tester (EPT) (Vitality Scanner, 
Sybron Endo Model 2006®, Orange, CA, USA). The primary 
outcome was a success of pulpal anesthesia. The anesthesia 
was considered successful when 2 consecutive no response at 
maximum (80) readings stimulation were obtained. Before 
the anesthesia was given, the experimental teeth and contra-
lateral control canine were tested by means of Vitality Scan-
ner to record the baseline vitality. The fluoride gel (Fluorogal 
Forte®, Galenika, Belgrade, Serbia) was used as an electro-
lyte between the tooth and pulp tester probe. The tip of pulp 
tester probe was placed in the middle third of the buccal side 
of tested teeth. The pulp response was tested immediately af-
ter the end of anesthetic application, from the central incisor 
through second premolar order, making the repeated meas-
urements for each tooth 4 minutes apart. 
The secondary outcomes were onset and duration of 
pulpal anesthesia. Onset time for anesthesia was defined as 
the time from completion of the anesthetic injection to the 
time when profound anesthesia was achieved EPT ≥ 80. The 
duration of pulpal anesthesia was a period between the first 
and the last 80 readings on EPT, what was considered to be 
profound anesthesia. 
Parameters of cardiovascular function 
The cardiovascular parameters, such as the systolic 
blood pressure (SBP), diastolic blood pressure (DBP) and 
heart rate (HR) were recorded by the electrocardiogram mon-
itor (Datex-Engstrom AS/3, Helsinki, Finland) 6 times: 5 
minutes prior anesthesia, during anesthetic injection, and 5, 
10, 15 and 30 minutes after administering anesthesia. Also, the 
participants were monitored for the potential changes in a car-
diac rhythm and the possible signs of myocardial ischemia. 
Statistical analysis 
The data concerning the demographic characteristics of 
participants were compared by the χ2-test. A success of pul-
pal anesthesia was evaluated by the descriptive statistical 
methods with the χ2-test and Fisher’s test for within group 
analysis and the McNemar test for between groups compari-
sons. The obtained differences in the onset and duration of 
pulpal anesthesia between the groups were tested for a sig-
nificance by the Wilcoxon Sign Rank test, while the Krus-
kall-Wallis test was used for within group analysis, followed 
by the Mann-Whitney U test. The parameters of cardiovascu-
lar function (SBP, DBP and HR) were analyzed by the two-
way repeated measures ANOVA with the group and time as 
the main factors. The changes of cardiovascular parameters 
over time within investigated groups (baseline vs. observed 
time intervals), were compared by means of one-way re-
peated measures ANOVA with the Bonferroni post hoc. Be-
tween group comparisons in the cardiovascular function at 
the observed time intervals were performed by the paired 
samples t-test. The statistical analysis was carried out using 
the SPSS 20.0 (Inc., Chicago, IL, USA) with the level of sig-
nificance set at 0.05. It was necessary to include at least 34 
participants to obtain 20% difference in the pulpal anesthesia 
duration between the techniques with 80% statistical power 
at a two-tailed level of significance 0.05 using the Mann 
Whitney U test. 
Results 
Demographic data and participants flow 
The participants flow is presented in Figure 1. Sixty-
seven participants were assessed for eligibility, and 40 of 
them were recruited to participate in this study. All partici-
pants received both treatments, but two of them had unsuc-
cessful anesthesia with both delivery systems and were ex-
cluded from the further analysis. The final number of ana-
lyzed participants with successful pulpal anesthesia of at 
least one tested tooth was 38, 20 females and 18 males, aging 
between 19 and 31 years (25.27 ± 2.46) with the mean body 
mass of 67.30 ± 15.03 kg/m2. 
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Enrollment Assessed for eligibility (n=67) 
Excluded (n=37)
 Not meeting inclusion criteria (n=21) 
 Declined to participate (n=6) 
 Other reasons (n=0) 
Allocation Randomized (n=40) 
Received AMSA with conventionalsyringe (n=40) 
Did not receive AMSA (n=0) 
Received AMSA with CCLADS (n=40) 
Did not receive AMSA (n=0) 
Follow-Up Follow-Up 
 
Lost to follow-up (n=0) 
 
Analyzed (n=38) 
Analysis Analysis 
 
Analyzed (n=38) 
 
Analyzed (n=38) 
E l d d f l i ( 0)  
Fig. 1 – Flow diagram of randomization to either conventional injection, or computer-controlled local anesthetic 
delivery system (CCLADS) for the anterior and middle superior alveolar (AMSA) nerve block (CONSORT Statement 
2010 Flow Diagram from Schulz KF, Altman DG, Moher D, for the CONSORT Group (2010) CONSORT 2010 
statement: Updated guidelines for parallel group randomized trials. J Pharmacol Pharmacother. doi: 10.4103/0976-
500X.72352). 
 
 
Parameters of pulpal anesthesia 
Successful pulpal anesthesia of all tested teeth was 
achieved in 22 (57.9%) participants of the CCLADS group 
and in 17 (44.7%) participants of the conventional syringe 
group. A success rate with CCLADS was 68.4% for the cen-
tral incisor, 100% for the lateral incisor and canine, 76.3% 
for the first premolar and 86.8% for the second premolar; 
with the conventional syringe, a successful anesthesia was 
achieved in 71% for the central incisor, 94.7% for the lateral 
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incisor, 81.6% for the canine, 71% for the first premolar and 
68.4% for the second premolar. Within group analysis of 
pulpal anesthesia a success rate in the CCLADS group re-
vealed: a significantly higher success for the lateral incisor in 
comparison with the central incisor (p < 0.001) as well as for 
the lateral incisor in comparison with the first premolar 
(p = 0.012), and also for the canine in comparison with the 
central incisor (p < 0.001), and for the canine compared to 
the first premolar (p = 0.012). In the conventional injection 
group, pulpal anesthesia was significantly more successful 
for the lateral incisor compared to the central incisor (p = 
0.012), for the lateral incisor compared to the first premolar 
(p = 0.012), as well as for the lateral incisor compared to the 
second premolar (p = 0.006). Between groups comparison 
showed that for the canine and second premolar a signifi-
cantly higher success rate of pulpal anesthesia was observed 
after CCLADS vs. conventional injection (Table 1).  
The onset and duration of pulpal anesthesia with con-
ventional syringe and CCLADS are presented in Table 2. 
The onset time was not significantly different between these 
2 investigated anesthetic techniques. Within group compari-
son revealed that there were no significant differences in the 
onset time among the teeth after the CCLADS injection. 
However, the onset of anesthesia was significantly longer in 
the conventional injection group for the central incisor in 
comparison with the lateral incisor (p = 0.024), for the cen-
tral incisor compared to the first premolar (p = 0.037), and 
also when the central incisor was compared to the second 
premolar (p = 0.022), as well as for the canine in comparison 
with the first premolar (p = 0.044). The significant differ-
ences in the pulpal anesthesia duration were not observed 
neither within nor between the investigated groups (Table 2). 
 
Table 1 
Success of pulpal anesthesia after anterior middle superior alveolar (AMSA) injection of 
4% articaine with conventional syringe and the computer-controlled local anesthetic 
delivery system (CCLADS) 
Delivery system Tooth Conventional syringe (n/N) CCLADS (n/N) pa 
Central incisor 27/38 26/38 ns 
Lateral incisor 36/38* 38/38* ns 
Canine 31/38 38/38* 0.016 
First premolar 27/38 29/38 ns 
Second premolar 26/38 33/38* 0.016 
pb 0.020                                            < 0.001   
N – number of participants; n – number of successfully anesthetized teeth. 
a – between groups comparison (McNemar test); b – within group comparisons (χ2-test, Fisher’s 
test post hoc); *p < 0.05: conventional injection for the lateral incisor vs. the central incisor 
(p = 0.012), the lateral incisor vs. the first premolar (p = 0.012), the lateral incisor vs. the second 
premolar (p = 0.006); the CCLADS injection for the lateral incisor vs. the central incisor 
(p < 0.001), the lateral incisor vs. the first premolar (p = 0.012), the canine vs. the central incisor 
(p < 0.001), the canine vs. the first premolar (p = 0.012). 
 
Table 2  
Onset and duration of successful pulpal anesthesia after the anterior middle superior alveolar (AMSA) injection of 4% 
articaine with a conventional syringe and the computer-controlled local anesthetic delivery system (CCLADS) 
Onset Duration 
Conventional CCLADS pa Conventional CCLADS pa Tooth 
(n) (n)  (n) (n)  
Central incisor  10.61 ± 5.31*   24.62 ± 18.92 28.31±15.79  
 (27) (26) 0.692 (27) (26) 0.411 
Lateral incisor 8.01 ± 4.17 8.00 ± 4.68 0.959 33.14 ± 19.95 28.11 ± 17.51 0.168 
 (36) (38)  (36) (38)  
Canine 9.45 ± 4.58* 8.68 ± 5.03 0.149 32.19 ± 17.04 29.58 ± 19.38 0.710 
 (31) (38)  (31) (38)  
First premolar 7.07 ± 5.45 7.74 ± 6.59 0.646 32.55 ± 14.30 26.34 ± 9.26 0.057 
 (27) (29)  (27) (29)  
Second premolar 7.08 ± 5.05 6.84 ± 5.02 0.896 31.62 ± 16.11 29.46 ± 17.94 0.407 
 (26) (33)  (26) (33)  
pb 0.042 0.172  0.251 0.821  
Values given in minutes as mean ± standard deviation (SD); n – number of successfully anesthetized teeth. 
abetween groups comparison (Wilcoxon Sign Rank test); b within group comparison (Kruskal-Wallis test, Mann-Whitney U 
test post hoc); *p < 0.05: conventional injection for the central incisor vs. the lateral incisor (p = 0.024), the central incisor vs. 
the first premolar (p = 0.037), the central incisor vs. the second premolar (p = 0.022); the canine vs. the first premolar 
(p = 0.044). 
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Parameters of cardiovascular function 
The two-way repeated measures ANOVA revealed a sig-
nificant effect of time factor for SBP (p < 0.001), DBP 
(p < 0.001) and HR (p = 0.008), with the significant interaction 
of main factors only for SBP (p = 0.010) (data not presented). 
The repeated measures one-way ANOVA with the Bon-
ferroni post hoc test in the CCLADS group showed a signifi-
cant decrease in SBP 5 minutes (p < 0.001), 10 minutes 
(p = 0.009) and 15 minutes (p = 0.008) after an injection in 
comparison with the baseline values; after conventional in-
jection, SBP was significantly lower after 10 minutes 
(p = 0.001), 15 minutes (p = 0.001) and 30 minutes 
(p = 0.029) when compared to the baseline values. Signifi-
cantly lower SBP was observed at 5th minute (p = 0.006) af-
ter conventional vs. CCLADS injection (Figure 2). 
The statistical analysis revealed that there was a signifi-
cant decrease in DBP over time in the CCLADS group at 5th 
minute (p = 0.037) and 10th minute (p = 0.036) when com-
pared to the baseline values, while after conventional injec-
tion, a significant decrease in DBP was observed after 10 
minutes (p = 0.001) and 15 minutes (p = 0.006) in compari-
son with the baseline values (Figure 3). 
The significant changes in HR were observed only in 
the CCLADS group during the observation time, with the 
significantly decreased values at 10th (p = 0.008), 15th 
(p = 0.008) and 30th minute (p = 0.003) when compared to 
the baseline (Figure 4). 
The changes in the cardiac rhythm and signs of myo-
cardial ischemia were not observed on electrocardiogram 
during the observation period. 
 
 
Fig. 2 – Changes in systolic blood pressure. 
a within group comparison, One-way repeated measures ANOVA (baseline vs. observed time interval, Bonferroni post 
hoc test); for CCLADS 5th min (p < 0.001), 10th min (p = 0.009), 15th min (p = 0.008); for conventional injection 10th 
min (p = 0.001), 15th min (p < 0.001), 30th min (p = 0.029). 
b between groups comparison, Paired samples t-test, 5th min (p = 0.006). 
CCLADS – computer controlled local anesthetic delivery system. 
 
 
Fig. – 3 Changes in diastolic blood pressure. 
a within group comparison; One-way repeated measures ANOVA (baseline vs. observed time interval, Bonferroni post 
hoc test); for CCLADS 5th min (p = 0.037), 10th min (p = 0.036); for conventional injection 10th min (p = 0.001), 15th 
min (p = 0.006). 
CCLADS – computer controlled local anesthetic delivery system. 
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Fig. 4 – Changes in heart rate. 
a within group comparison, One-way repeated measures ANOVA (baseline vs. observed time interval, Bonferroni post 
hoc test); for the CCLADS 10th min (p = 0.008), 15th min (p = 0.003), 30th min (p = 0.003). 
CCLADS – computer controlled local anesthetic delivery system. 
 
Discussion 
This prospective, controlled double-blind, cross-over 
randomized clinical study in the healthy volunteers evaluated 
and compared the anesthetic and cardiovascular effects of 
0.6 mL 4% articaine with epinephrine (1:100.000) used for 
the AMSA nerve block delivered by the computer-controlled 
delivery system and conventional syringe. 
The overall success rate of pulpal anesthesia, as a pri-
mary outcome of the study, with CCLADS ranged from 
68.4% to 100%, while with conventional syringe, it was be-
tween 68.4% and 94.7%. Pulpal anesthesia in the present 
study was considered successful if two, or more consecutive 
80 readings were obtained by the electrical pulp test without 
the participant’s response. Regarding the fact that the pa-
rameters of pulpal anesthesia after the AMSA nerve block 
obtained with articaine with epinephrine were not investi-
gated, the available evidence concern the use of 2% lidocaine 
with epinephrine as a “gold standard”. Namely, in the study 
of Fukayama et al. 3, the lower success rates were observed 
(between 42% and 72%), based on one registered 80 reading 
without a participant’s response during the electrical stimula-
tion, after the AMSA nerve block obtained with 1.8 mL of 
2% lidocaine with epinephrine 1 : 80.000 delivered by the 
computer controlled system WAND. Similarly low success 
rates, evaluated according to two consecutive 80 readings 
without a participant’s response to the electric pulp test, were 
also reported in a comparative study by Lee et al. 5 during the 
60-minute observation period, after 1.4 mL of 2% lidocaine 
with 1 : 100.000 epinephrine delivered for the AMSA nerve 
block, either by computer controlled system (success rate be-
tween 35% and 58%), or using conventional syringe (success 
rate between 20% and 42%). On the other hand, Corbett et 
al. 6 reported a higher anesthetic success of pulpal anesthesia 
(between 42% and 85%) during the 47-minute observation 
period, regarding minimum two consecutive 80 readings 
without a response to the electrical stimuli, when 1 mL of 
2% lidocaine with epinephrine 1 : 80.000 was delivered with 
the WAND system for the AMSA nerve block in comparison 
with the infraorbital nerve block. Considering factors that in-
fluence a success rate of pulpal anesthesia, as an important 
parameter of anesthesia quality, several of them, such as the 
anesthetic pharmacological profile, regional anatomical spec-
ificity and local anesthesia technique, could contribute to a 
higher success rate of local intraoral anesthesia. Since no dif-
ference was observed between delivery systems (CCLADS 
and conventional cartridge-syringe), our results could be ex-
plained rather by pharmacological properties of local anes-
thetic applied than the anesthetic technique used. Articaine is 
an amide local anesthetic with the characteristic molecular 
structure that includes the presence of tiophene ring. The 
presence of tiophene ring increases the anesthetic liposolu-
bility, and it is suggested that articaine diffuses more readily 
through the soft and bone tissue than other local anesthetics. 
Increased lipid solubility of articaine (partition coefficient 
17) in comparison with lidocaine (partition coefficient 4) 
permits the more active anesthetic molecules to effectively 
penetrate the lipid nerve membrane, what is reflected in the 
increased anesthetic potency of articaine. Concerning that, it 
is clear that articaine provides higher rates of pulpal anesthe-
sia success than lidocaine when used for infiltration and 
block anesthesia during the routine dental treatments 11. 
Further analysis of success rate in the present study 
compared the efficacy of CCLADS and conventional syringe 
delivery in obtaining successful pulpal anesthesia of specific 
teeth. Our results showed that pulpal anesthesia of canine 
and second premolar was significantly more successful after 
CCLADS injection in comparison with conventional injec-
tion. A significantly higher success rate of pulpal anesthesia 
using CCLADS compared to conventional injection was also 
observed in a comparative study by Lee et al. 5, but for all 
tested teeth from the lateral incisor to the second premolar 
after the AMSA nerve block achieved with 1.4 mL of 2% li-
docaine with epinephrine 1 : 100.000. A lower success rate 
obtained with conventional injection could be due to the dif-
ference in the pressure gradient and flow rate between com-
puter controlled and conventional delivery, since, using 
computer controlled delivery system, both factors were more 
precisely controlled and constant, providing the better condi-
tions for anesthetic solution diffusion through the alveolar 
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and palatal bone. Furthermore, within the groups, the most 
successful pulpal anesthesia was observed for the lateral in-
cisor and canine, while the lowest success rate was observed 
for the central incisor and first premolar regardless the deliv-
ery system used. The obtained results could be explained by 
the anatomical variability in innervation of the anesthetized 
area, since it is possible that the buccal root of the first pre-
molar may be innervated by the accessory branches of poste-
rior superior alveolar nerve 12. Also, the buccal position of 
the root defines the greater distance and diffusion path of an-
esthetic solution which is deposited palatal. Similarly, the 
distance of central incisor’s root from the deposition site 
could affect diffusion of anesthetic solution, leading to a 
comparatively lower pulpal anesthesia success rate.  
The onset of pulpal anesthesia was similar between the 
investigated groups in our study. The results of previous 
studies, after the AMSA nerve block performed with 2% li-
docaine with epinephrine, showed that the onset time ranged 
between 5 and 11 minutes with CCLADS delivery system, 
and between 6 and 12 minutes with conventional injection 
delivery 4, 6. Similar results were obtained in our study. Simi-
larly to the previously mentioned studies, the longer onset 
time was observed for the central incisor and canine, using 
both delivery systems. It is possible that this delay in the on-
set was due to a greater diffusion distance of anesthetic solu-
tion through the alveolar and palatal bone 6.  
Only two studies reported that the duration of pulpal 
anesthesia after the AMSA nerve block was achieved with 
2% lidocaine with epinephrine. In a study by Fukayama et 
al. 3, the authors reported the duration of pulpal anesthesia up 
to 40 minutes, including all tested teeth from the central inci-
sor to the first molar, after the AMSA nerve block obtained 
with 2% lidocaine with epinephrine 1:80.000 using 
CCLADS delivery system. Similarly, Velasco and Soto 4 ob-
served the duration of pulpal anesthesia of tested teeth be-
tween 23 and 40 minutes when 2% lidocaine with epineph-
rine 1:100.000 was applied with the conventional cartridge-
syringe 4. However, in the mentioned studies, the statistical 
analysis of pulpal anesthesia duration was not performed due 
to a low number of participants with a successful pulpal an-
esthesia. In the present controlled clinical study, with con-
firmed statistical power, duration of pulpal anesthesia com-
paring two delivery systems was similar and ranged from 24 
to 32 minutes for conventional syringe delivery, and between 
26 to 29 minutes for CCLADS. Regarding the pharmacol-
ogical profile of articaine, the degree of articaine protein 
binding (95%), which is higher than that of lidocaine (65%), 
is expected to ensure the more firm attachment of articaine 
molecules to the protein receptors sites, responsible for a 
longer duration of clinical activity. However, further com-
parative study of articaine and lidocaine might confirm anes-
thetic superiority concerning anesthesia duration after arti-
caine delivery for the AMSA nerve block. 
It still remains unclear whether the AMSA nerve block 
truly acts as a nerve block, since anesthetic solution is not 
deposited directly in the vicinity of any main nerve trunk. 
Furthermore, a success as well as duration of pulpal anesthe-
sia varied with the distance and bone thickness between the 
tooth apex and deposition site, which favors more tissue in-
filtration as a type of anesthesia, over the nerve block con-
duction 6. Taking all together, there could be a possibility 
that the AMSA nerve block acts as an intraosseous injection, 
which directly reflects to a significance of articaine + epi-
nephrine safety profile. This route of administration, due to 
the deposition of local anesthetic in the highly vascularized 
bone area, allows the rapid resorption of both, local anes-
thetic and vasoconstrictor. Therefore, the safety profile of 
AMSA nerve block in the present study was evaluated by the 
cardiovascular parameters monitoring. The systolic blood 
pressure was a significantly decreased within CCLADS 
group from 5th to 15th minutes in comparison with the base-
line values, and in the conventional group, from 10th to 30th 
minute when compared to the baseline. At the 5th minute, 
the systolic blood pressure significantly increased after the 
conventional injection in comparison with CCLADS. The 
decreased systolic blood pressure within both groups in our 
study implies a good safety of AMSA technique with regard 
to cardiovascular stability, which is supported also by the de-
creased values of diastolic blood pressure from 5th to 10th 
minute for the CCLADS injection and from 10th to 15th mi-
nute for conventional injection, in comparison with the base-
line values. A heart rate was significantly decreased only in 
the CCLADS group from 10th to 30th minutes, which sug-
gests the more preferable cardiovascular profile after 
CCLADS injection, since the heart rate is a cardiovascular 
parameter that is the most sensitive to the exogenous epi-
nephrine effects 13. 
Conclusion 
In conditions of the present double-blind randomized 
controlled cross-over clinical study, the efficacy of pulpal 
anesthesia, especially for the lateral incisor and canine as 
well as safety of cardiovascular profile of 0.6 mL of articaine 
with epinephrine (1:100.000) delivered using CCLADS 
overcome conventional syringe delivery. 
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